Research on COVID-19 vaccination strategies in Singapore.
10.3760/cma.j.cn112338-20211125-00919
- Author:
He Ya YI
1
;
Jie Mi ZHAO
1
;
Xiao Feng LIANG
2
;
Teo Yik YING
3
Author Information
1. Chinese Preventive Medicine Association, Beijing 100021, China.
2. Chinese Preventive Medicine Association, Beijing 100021, China Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China.
3. National University of Singapore, Singapore City 119077, Singapore.
- Publication Type:Journal Article
- MeSH:
COVID-19/prevention & control*;
COVID-19 Vaccines;
Humans;
Immunization Programs;
Singapore;
Vaccination
- From:Chinese Journal of Epidemiology
2022;43(3):310-314
- CountryChina
- Language:Chinese
-
Abstract:
As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.
